| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical Inc. (RARE) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. RARE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 132.7K | $3.51M | - | |
| CFO | 88.9K | $2.35M | - | |
| Other | 79.9K | $2.12M | - | |
| Other | 79.9K | $2.12M | - | |
| VP | 50.5K | $1.33M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 2022 | Dier Mardi70 | CFO &Executive Vice President | Sell | 1,629 | $40.16 | $65,420.64 | -2.4% | +16.5% | -9.4% | |
| Oct 12, 2022 | Dier Mardi70 | CFO &Executive Vice President | Sell | 3,484 | $38.22 | $133,158.48 | -4.9% | +12.9% | -15.2% | |
| Jun 19, 2022 | Harris Erik75 | EVP &Chief Commercial Officer | Sell | 295 | $54.78 | $16,160.10 | -0.8% | -17.2% | -9.8% | |
| Apr 16, 2022 | Huizenga Theodore Alan65 | SVP, Chief Accounting Officer | Sell | 132 | $84.55 | $11,160.60 | -0.8% | -17.5% | -48.0% | |
| Mar 11, 2022 | Kassberg Thomas Richard68 | Cbo &EVP | Sell | 10,281 | $67.01 | $688,929.81 | -4.3% | -21.9% | -40.7% | |
| Mar 7, 2022 | Parschauer Karah Herdman77 | EVP And Chief Legal Officer | Sell | 5,140 | $62.95 | $323,563.00 | -13.0% | -21.8% | -32.3% | |
| Mar 3, 2022 | Dier Mardi70 | CFO &Executive Vice President | Sell | 954 | $65.71 | $62,686.08 | -1.0% | -28.0% | -28.7% | |
| Mar 1, 2022 | Bedrosian Camille L64 | EVP And Chief Medical Officer | Sell | 2,821 | $66.62 | $187,935.02 | -7.7% | -30.4% | -32.2% | |
| Mar 1, 2022 | Harris Erik75 | EVP &Chief Commercial Officer | Sell | 2,713 | $66.62 | $180,740.06 | -10.8% | -30.4% | -32.2% | |
| Mar 1, 2022 | Pinion John Richard73 | See Remarks | Sell | 4,498 | $66.62 | $299,656.76 | -9.0% | -30.4% | -32.2% |